Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wim Hissink Muller"'
Autor:
Wim Hissink Muller, Boerbooms Am, Ronney A. De Abreu, Henk J. Van Beusekom, J. Stolk, Leo B A van de Putte, Diana G. M. de Koning
Publikováno v:
Arthritis & Rheumatism. 41:1858-1866
Objective To investigate thiopurine enzyme activities for their possible value in predicting the development of azathioprine (AZA)-related toxicity in patients with rheumatoid arthritis (RA). Methods Patients with longstanding RA (n = 33) were enroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893d85452135ffdf03a98004b0617579
https://doi.org/10.1002/1529-0131(199810)41:10<1858::aid-art19>3.0.co
https://doi.org/10.1002/1529-0131(199810)41:10<1858::aid-art19>3.0.co
Autor:
Boerbooms Am, M.J.A.M. Franssen, Johannes J. Rasker, Wim Hissink Muller, Dirk-Jan R. A. M. De Rooy, Joost F. Haverman, Wim H. Doesburg, Levinus B. A. van de Putte, Henk J. Van Beusekom, Marijn W. M. Kruijsen, M. E. C. Jeurissen, Jan Mulder
Publikováno v:
Arthritis & Rheumatism. 34:961-972
We conducted a double-blind, randomized trial comparing azathioprine (AZA) and methotrexate (MTX) in the treatment of patients with rheumatoid arthritis in whom parenteral gold and/or D-penicillamine treatment had been unsuccessful. Patients were ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e604b22254188a36cab99e41c93d72
https://doi.org/10.1002/art.1780340805
https://doi.org/10.1002/art.1780340805